Digital Health Startups

Fortified Health Security is a managed security services provider (MSSP) focused on healthcare, offering 24/7 cybersecurity monitoring, threat defense, and incident response to protect patient data. Its Central Command platform consolidates cybersecurity program management for healthcare systems in the U.S. and globally.

2 investors

Fortuna modernizes the infrastructure and consumer experience for Medicaid and government health programs. The company focuses on improving enrollment, eligibility verification, and access to coverage for Medicaid, CHIP, and Marketplace beneficiaries.

2 investors

Foundation Health offers an AI operating system for pharmacies that automates prior authorizations, refill authorizations, financial assistance enrollment, 340B compliance, and patient communications, along with a white-labeled digital pharmacy front door and a healthcare API. It serves health systems, health plans/insurers, and developers, primarily in the US healthcare and pharmacy market.

2 investors

Fourier Health builds infrastructure to unlock unstructured clinical data from healthcare systems, enabling AI models and clinicians to access actionable intelligence from records currently locked in PDFs and fragmented systems. The company serves healthcare providers, researchers, and AI developers seeking trustworthy clinical data integration and analysis.

2 investors

Fovionics develops smart glasses for blind and visually impaired people, aimed at assisting with reading and daily tasks. The company focuses on making assistive vision technology affordable, with roots addressing accessibility gaps in Brazil.

2 investors

Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System. It plans to expand into bladder and kidney cancer applications, aiming to reduce the side effects associated with conventional prostate treatments.

2 investors

Freed builds an AI assistant for clinicians that generates clinical notes from patient encounters, offering customizable templates, visit prep summaries, patient-friendly instructions, referral and other letters, and suggested billable ICD-10, CPT, and E/M codes that can sync to an EHR. It serves healthcare providers looking to reduce documentation time.

2 investors

Frontera Health builds AI tools that help clinicians write behavioral health assessments and diagnostic reports for children with autism and related disorders, cutting documentation time and reducing waitlists. Its Assessment Builder and Diagnosis Builder analyze unstructured text, video, and voice data and are designed to serve ABA practitioners, clinical psychologists, and families facing barriers to care.

2 investors

Fundamental VR develops immersive extended reality (XR) training solutions for clinical and medical device professionals, enabling faster skill acquisition and competency development through interactive 3D simulations and digital twins of medical procedures.

2 investors

Future Fertility develops non-invasive, AI-based tools that assess oocyte (egg) quality from images, using a large image dataset to provide an objective evaluation method. The products are aimed at fertility clinics.

2 investors

GalenusCare (ChorusRx) provides precision pharmacy services for PACE and hospice care programs, combining clinical pharmacists with AI-powered analytics to optimize medication regimens, reduce adverse drug events, and lower medical costs. Its services include medication regimen optimization, precision compliance packaging, symptom kits, and collaborative pharmacy management with value-based care agreements.

2 investors

Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights. The service analyzes DNA samples to deliver personalized health recommendations across core health areas, ancestry information, and integrates with labs, wearables, and lifestyle data.

2 investors

Gene S is an Australian biotechnology company offering a Next Generation Sequencing (NGS) pharmacogenomic testing platform, called Rosa, with gene testing and reporting software for laboratories and doctors. Its first product, RosaMind, guides medication selection and dosing for mental health conditions, with planned expansion to pain, cardiac, anaesthesia, and other therapeutic areas.

2 investors

GenEmbryomics provides comprehensive preimplantation genetic screening of IVF embryos using whole genome sequencing, screening for chromosome abnormalities, mosaicism, and thousands of inherited and new genetic mutations. It serves patients and families undergoing IVF, delivering reports to help select embryos with the lowest genetic disease risk.

2 investors

GenePath provides molecular diagnostic and genomic testing services and products for infectious diseases, oncology, and inherited genetic disorders, serving clinical healthcare and research markets globally since 2008.

2 investors

General Medicine connects patients with clinicians and local specialists to address individual healthcare needs. The company provides personalized healthcare coordination services.

2 investors

Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.

2 investors

Genesis Therapeutics applies artificial intelligence to discover and develop drugs for challenging targets, combining machine learning with biotech research. It operates in the AI-driven drug discovery space.

2 investors

Genknowme provides epigenetic blood tests that measure biological age and stress overload to guide individuals and healthcare professionals toward healthier aging and better stress management. The company's tests assess how lifestyle and environmental factors influence DNA methylation patterns and aging processes.

2 investors

Genobank provides a platform for patients to own, control, and monetize their genomic data through blockchain-linked biosamples and AI-powered bioinformatics workflows. The platform enables patients to share their biological data with researchers and clinical trials while maintaining transparency and earning potential from data licensing.

2 investors

LifeView provides preimplantation genetic testing for IVF embryos, including screening for chromosomal abnormalities (PGT-A/A+), single-gene disorders (PGT-M), structural rearrangements (PGT-SR), and its Embryo Health Score polygenic risk test. Its services target prospective parents and fertility clinics seeking to improve IVF success rates and reduce miscarriage and genetic disease risk.

2 investors

Genomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.

2 investors

Genese Technologies makes mediscan, a portable AI-based health screening device (device, belt, and app) that performs non-invasive preventative screening and chronic disease monitoring for liver, lung, and kidney health. It generates personalized health reports in minutes for use in clinics, community centers, at-home, corporate wellness, and telemedicine settings.

2 investors

Gerocare provides in-home primary healthcare services for elderly individuals, including monthly doctor visits, laboratory testing, teleconsultation, caregiving, and health monitoring through a subscription model in Nigeria.

2 investors